Accutrend® Plus system

Screening for cardiovascular risk factors

Product image for Accutrend ® Plus system
Do you have any questions?

Screening for cardiovascular risk factors

  • A significant number of patients in primary care are dyslipidemic and therefore at higher risk of cardiovascular disease1-3
  • In addition, many patients with lipid dis­orders are either treated insufficiently or not treated at all1
  • Point of care lipid testing can substantially improve recognition as well as management of dyslipidemic patients in primary care1


Safety and reassurance


  • Built-in automatic performance testing and meter self-testing for reliable results


Ease of use


  • Simplicity makes device ideal for testing in the physician office or in hospital ­settings


Product characteristics


  • Convenient determination of cholesterol, triglycerides, glucose and lactate using capillary blood
  • Positive control strip and parameter ­recognition are used for calibration
  • Test strips can be stored at room ­temperature
  • Can store up to 100 different measurements with date, time and flags
  • Great precision and accuracy across the measuring range
Product image forcobas b 101 system

Système cobas b 101

Votre quotidien entre de bonnes mains


Measuring ranges

Measuring time

Sample material

Sample volumes

Operating conditions






12 sec

  • Fresh capillary blood

15–50 µ L

18° – 35°C




180 sec

  • Fresh capillary blood
  • Use of heparin-coated pipettes possible

15–40 µ L

18° – 35°C




max. 174 sec

  • Fresh capillary blood
  • Use of heparin-coated pipettes possible

10–40 µ L

18° – 30°C


0.8–22 mmol/L

60 sec

  • Fresh capillary blood
  • Use of heparin-coated pipettes possible

15–50 µ L

5° – 35°C or
15° – 35°C depending on concentration of analyte


Simplifiez-vous la vie

commandez online

  1. Taylor, J.R. and Lopez, A.M. (2004), Cholesterol: pointofcare testing. Ann Pharmacother 38: 1252-1257.
  2. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362:271-280.
  3. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24:1601-1610.